|
ATCC
human hepatocytes hepg2 cells ![]() Human Hepatocytes Hepg2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+hepatocyte+hepg2/Hep+G2/pmc13754849-334-0-4 Average 99 stars, based on 1 article reviews
human hepatocytes hepg2 cells - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
hepg2 human caucasian hepatocyte carcinoma cell line ![]() Hepg2 Human Caucasian Hepatocyte Carcinoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+hepatocyte+hepg2/Hep+G2/bio_rxiv__64898__2026__05__15__725388-264-3-11 Average 99 stars, based on 1 article reviews
hepg2 human caucasian hepatocyte carcinoma cell line - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
human hepatocyte cell line hepg2 ![]() Human Hepatocyte Cell Line Hepg2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+hepatocyte+hepg2/Hep+G2/pmc13160715-64-1-10 Average 99 stars, based on 1 article reviews
human hepatocyte cell line hepg2 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
human hepg2 hepatocytes ![]() Human Hepg2 Hepatocytes, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+hepatocyte+hepg2/Hep+G2/pm41950778-150-0-7 Average 99 stars, based on 1 article reviews
human hepg2 hepatocytes - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
hepg2 human hepatocyte cell line ![]() Hepg2 Human Hepatocyte Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+hepatocyte+hepg2/Hep+G2/10__3390_slash_molecules31050876-177-7-17 Average 99 stars, based on 1 article reviews
hepg2 human hepatocyte cell line - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
human hepatocyte carcinoma hepg2 cells ![]() Human Hepatocyte Carcinoma Hepg2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+hepatocyte+hepg2/Hep+G2/pmc12854047-64-0-21 Average 99 stars, based on 1 article reviews
human hepatocyte carcinoma hepg2 cells - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
Procell Inc
human hepatocyte hepg2 ![]() Human Hepatocyte Hepg2, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+hepatocyte+hepg2/cells+hepg2/pm41654271-85-0-6 Average 86 stars, based on 1 article reviews
human hepatocyte hepg2 - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
Journal: Nature Communications
Article Title: Fever enhances host bacterial defence while limiting mitochondrial damage
doi: 10.1038/s41467-026-78498-6
Figure Lengend Snippet: a Representative structured illumination microscopy (SIM) images of mitochondria (magenta) and lipid droplets (cyan) in human hepatocytes HepG2 cells cultured with or without 4.5 g/L glucose. White lines indicate the contact regions. Green arrows indicate LDs without mitochondrial contact; orange arrows indicate contacted LDs. b Quantification of lipid droplet-mitochondria contact area in HepG2 from three biological replicates. c Representative SIM images of mitochondria (magenta) and lipid droplets (cyan) in Drosophila S2R+ cells. d Lipid droplet-mitochondria contact area for S2R+ cells. Contact ratios were computed by normalizing the total contact area by the total lipid droplet volume. Three biological replicates were done for each condition. Data points represent the average contact ratio from independent experiments, for which at least 50 cells were imaged. Black bars indicate the mean of independent experiments, and error bars represent SEM from three replicates. Scale bars represent 2 μm. Two-sided Welch’s t-tests with unequal variances were performed. No adjustments were made for multiple comparisons. P -values greater than 0.05 are considered non-significant (ns).
Article Snippet:
Techniques: Structured Illumination Microscopy, Cell Culture, Drosophila
Journal: Frontiers in Pharmacology
Article Title: Downregulation of microRNA-300-3p promotes steatosis-to-MASH progression by regulating STX17
doi: 10.3389/fphar.2026.1804415
Figure Lengend Snippet: MiR-300-3p was decreased in the livers of MAFLD mice and FFA-induced HepG2 cells. (A) MiR-300-3p was decreased in the livers of MAFLD mice. (B) MiR-300-3p was downregulated in the FFA-induced HepG2 cells. (C) MiR-300-3p was downregulated in HepG2 cells successfully. (D) MiR-300-3p was overexpressed in HepG2 cells successfully. Data in (A–D) are means±SDs (n = 3). *P < 0.05, **P < 0.01. NC, Healthy control; OC, over-expression control; IC, inhibition control.
Article Snippet: The
Techniques: Control, Over Expression, Inhibition
Journal: Frontiers in Pharmacology
Article Title: Downregulation of microRNA-300-3p promotes steatosis-to-MASH progression by regulating STX17
doi: 10.3389/fphar.2026.1804415
Figure Lengend Snippet: Downregulation of miR-300-3p promotes FFA-induced lipid accumulation and hepatic inflammation in HepG2 cells. (A) The experimental flow of the MAFLD cell model construction and miR-300-3p mimics, miR-300-3p inhibitors and as well as corresponding scrambled controls transfection in HepG2 cells. (B,C) Intercellular TG contents in miR-300-3p -inhibited and -overexpressing in HepG2 cells. (D) Oil Red O staining (400×) and the relative areas of lipid droplets in miR-300-3p-inhibited and -overexpressing in HepG2 cells. (E,F) mRNA levels of FASN, SREBP-1c, IL-6, IL-2 and TNF-αin miR-300-3p -inhibited and -overexpressing in HepG2 cells. (G) Protein levels of FASN, SREBP-1c and TNF-α in miR-300-3p -inhibited and -overexpressing in HepG2 cells. Data in (B,C) and (E–G) are means±SDs (n = 3). *P < 0.05, **P < 0.01, *** P < 0.001, **** P < 0.0001. OC, over-expression control; IC, inhibition control.
Article Snippet: The
Techniques: Transfection, Staining, Over Expression, Control, Inhibition
Journal: Frontiers in Pharmacology
Article Title: Downregulation of microRNA-300-3p promotes steatosis-to-MASH progression by regulating STX17
doi: 10.3389/fphar.2026.1804415
Figure Lengend Snippet: Downregulation of miR-300-3p induces apoptosis in HepG2 cells to promote it. (A,B) The apoptosis rate in miR-300-3p -inhibited and -overexpressing in HepG2 cells. (C) mRNA levels of Bax, Bcl-2 and Caspase-3 in miR-300-3p -inhibited and -overexpressing in HepG2 cells. (D) Protein levels of Bax, Bcl-2 and Caspase-3 in miR-300-3p -overexpressing and -inhibited in HepG2 cells. Data in (A–D) are means±SDs (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. OC, over-expression control; IC, inhibition control.
Article Snippet: The
Techniques: Over Expression, Control, Inhibition
Journal: Frontiers in Pharmacology
Article Title: Downregulation of microRNA-300-3p promotes steatosis-to-MASH progression by regulating STX17
doi: 10.3389/fphar.2026.1804415
Figure Lengend Snippet: MiR-300-3p regulates STX17 in HepG2 cells. (A,B) GO enrichment analysis (Biological Process category) and KEGG enrichment analysis diagrams of sixteen predicted target genes of miR-300-3p. (C) The predicted binding sites between miR-300-3p and STX17 were putatively identified via the TargetScan database. (D) Dual-luciferase reporter assay (DLRA) in HepG2 cells validated that STX17 is a direct target gene of miR-300-3p. (E,F) The mRNA and protein expression levels of STX17 in HepG2 cells with miR-300-3p inhibition or overexpression. Data in (A–D) are means±SDs (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. OC, overexpression control; IC, inhibition control.
Article Snippet: The
Techniques: Binding Assay, Luciferase, Reporter Assay, Expressing, Inhibition, Over Expression, Control
Journal: Frontiers in Pharmacology
Article Title: Downregulation of microRNA-300-3p promotes steatosis-to-MASH progression by regulating STX17
doi: 10.3389/fphar.2026.1804415
Figure Lengend Snippet: P62 and LC3-II in miR-300-3p -inhibited and -overexpressing in HepG2 cells. (A) The protein levels of P62 and LC3-II in miR-300-3p -inhibited and -overexpressing in HepG2 cells. (B) P62 and LC3-II in miR-300-3p -inhibited and -overexpressing by Immunofluorescence assay. Data in (A-D) are means±SDs (n = 3). *P < 0.05, **P < 0.01,***P < 0.001,****P < 0.0001. OC, overexpression control; IC, inhibition control.
Article Snippet: The
Techniques: Immunofluorescence, Over Expression, Control, Inhibition
Journal: Frontiers in Pharmacology
Article Title: Downregulation of microRNA-300-3p promotes steatosis-to-MASH progression by regulating STX17
doi: 10.3389/fphar.2026.1804415
Figure Lengend Snippet: MiR-300-3p promoted autophagy by regulating STX17, reduces lipid accumulation, inflammatory response, and decreases hepatocyte apoptosis. (A) STX17 was inhibited or overexpressed in HepG2 cells successfully. (B) Protein levels of FASN, SREBP-1c and TNF-αin STX17 -inhibited and -overexpressing in HepG2 cells. (C,D) Intercellular TG contents in STX17-inhibited and -overexpressing in HepG2 cells. (E) Oil Red O staining (400×) and relative areas of lipid droplets in STX17-inhibited and -STX17 in HepG2 cells. (F) Protein levels of Bax, Capase-3 and Bcl-2 in STX17 -inhibited and -overexpressing in HepG2 cells. Data in (A–D) and (F) are means±SDs (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. OC, miR-300-3p overexpression control; IC,miR-300-3p inhibition control; Control, STX17-overexpression control or STX17-inhibition control; Si-STX17, STX17-inhibition; Over-STX17, STX17-overexpression.
Article Snippet: The
Techniques: Staining, Over Expression, Control, Inhibition
Journal: Frontiers in Pharmacology
Article Title: Downregulation of microRNA-300-3p promotes steatosis-to-MASH progression by regulating STX17
doi: 10.3389/fphar.2026.1804415
Figure Lengend Snippet: P62, LC3-II in STX17-inhibited and -overexpressing in HepG2 cells. (A) Protein levels of P62, LC3-II in STX17-inhibited and -overexpressing in HepG2 cells. (B) P62 and LC3-II in STX17-inhibited and -overexpressing by Immunofluorescence assay. Data in (A-D) are means±SDs (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. OC, overexpression control; IC, inhibition control.
Article Snippet: The
Techniques: Immunofluorescence, Over Expression, Control, Inhibition
Journal: Biotechnology Reports
Article Title: Insulin Resistance, Anti-inflammatory, and Antioxidant In vitro Activity of Heterologously Expressed Arenin from Dryophytes arenicolor
doi: 10.1016/j.btre.2026.e00947
Figure Lengend Snippet: In vitro modulation of hepatic insulin resistance by arenin in hepatic insulin-resistant (HepG2) cells . Arenin concentrations (3.90–1000 µg/mL) were incubated for 5 h in hepatic insulin-resistant cells. Negative control (N) cells were cultured in the absence of insulin, whereas insulin-resistant (IR) control cells were cultured in the presence of insulin. Rosiglitazone (ROSI) at 10 μM (3.57 µg/mL) was used as the positive reference control. Different letters abc indicate statistical differences between concentrations analyzed using Tukey test ( p < 0.05).
Article Snippet:
Techniques: In Vitro, Incubation, Negative Control, Cell Culture, Control